CSF-1 receptor signaling in myeloid cells.
Open accessThe DOI matches its Crossref record; 207 of the 211 references it cites were found in a registry or an index.
Abstract
The CSF-1 receptor (CSF-1R) is activated by the homodimeric growth factors colony-stimulating factor-1 (CSF-1) and interleukin-34 (IL-34). It plays important roles in development and in innate immunity by regulating the development of most tissue macrophages and osteoclasts, of Langerhans cells of the skin, of Paneth cells of the small intestine, and of brain microglia. It also regulates the differentiation of neural progenitor cells and controls functions of oocytes and trophoblastic cells in the female reproductive tract. Owing to this broad tissue expression pattern, it plays a central role in neoplastic, inflammatory, and neurological diseases. In this review we summarize the evolution, structure, and regulation of expression of the CSF-1R gene. We discuss the structures of CSF-1, IL-34, and the CSF-1R and the mechanism of ligand binding to and activation of the receptor. We further describe the pathways regulating macrophage survival, proliferation, differentiation, and chemotaxis downstream from the CSF-1R.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“DAP12 is a mediator of CSF1R proliferation pathway through MAPK and Akt. DAP12 ITAM domain is phosphorylated following CSF1R activation triggering ß catenin, a molecule that acts on cellular cycle (1).”
From Role of Macrophage Colony-Stimulating Factor Receptor on the Proliferation and Survival of Microglia Following Systemic Nerve and Cuprizone-Induced Injuries (2020) · cites this paper as [1]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Unlike non-plaque-associated (distal microglia; Extended Data Fig. 1b) or PU.1high plaque-associated microglia, this subpopulation appears independent of the activity of the essential microglial survival receptor CSF1R26,27 (Fig. 1d,e and Extended Data Fig. 1b–d).”
From Lymphoid gene expression supports neuroprotective microglia function (2025) · cites this paper as [27]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We examined the expression of CSF1 and IL34, two well characterized microglial mitogens, which both function by activating the CSF1 receptor (CSF1R) (Stanley & Chitu, 2014).”
From Activated microglia drive demyelination via CSF1R signaling (2021) · cites this paper as Stanley & Chitu, 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“M-CSF signaling is crucial to brain macro phage function, and phosphorylation of Y561 is known to relieve autoinhibition of the M-CSF receptor (Stanley and Chitu, 2014).”
From Alzheimer’s genetic risk factor CASS4 controls microglial focal adhesion biology and amyloidosis (2026) · cites this paper as Stanley and Chitu, 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“ELISA showed that Plexin-B1-deficient astrocytes showed reduced expression of 12 proteins, including CSF-1, a major cytokine for myeloid cell stimulation47, and ICAM-1, which acts as an inflammatory mediator in the CNS that stimulates the production and secretion of interleukins48 (Fig. 6C).”
From Regulation of cell distancing in peri-plaque glial nets by Plexin-B1 affects glial activation and amyloid compaction in Alzheimer’s disease (2024) · cites this paper as [47]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sherr, C. J., Rettenmier, C. W., Sacca, R., Roussel, M. F., Look, A. T., & Stanley, E. R. (1985) · Cell · doi:10.1016/s0092-8674(85)80047-7 · Cited by 1,540
Self-citationYarden, Y., Escobedo, J. A., Kuang, W.-J., Yang-Feng, T. L., Daniel, T. O., Tremble, P. M., Chen, E. Y., Ando, M. E., Harkins, R. N., Francke, U., et al. (1986) · Nature · doi:10.1038/323226a0 · Cited by 1,209
Dai, X.-M., Ryan, G. R., Hapel, A. J., Dominguez, M. G., Russell, R. G., Kapp, S., Sylvestre, V., & Stanley, E. R. (2002) · Blood · doi:10.1182/blood.v99.1.111 · Cited by 1,184
Self-citationTrophic macrophages in development and disease
Pollard, J. W. (2009) · Nature Reviews Immunology · doi:10.1038/nri2528 · Cited by 1,178
Wang, Y., Szretter, K. J., Vermi, W., Gilfillan, S., Rossini, C., Cella, M., Barrow, A. D., Diamond, M. S., & Colonna, M. (2012) · Nature Immunology · doi:10.1038/ni.2360 · Cited by 1,011
Discovery of a Cytokine and Its Receptor by Functional Screening of the Extracellular Proteome
Lin, H., Lee, E., Hestir, K., Leo, C., Huang, M., Bosch, E., Halenbeck, R., Wu, G., Zhou, A., Behrens, D., et al. (2008) · Science · doi:10.1126/science.1154370 · Cited by 817
CSF-1 regulation of the wandering macrophage: complexity in action
Pixley, F. J., & Stanley, E. R. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.09.016 · Cited by 807
Self-citationStanley, E. R., & Heard, P. M. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40265-1 · Cited by 739
Self-citationTushinski, R. J., Oliver, I. T., Guilbert, L. J., Tynan, P. W., Warner, J. R., & Stanley, E. R. (1982) · Cell · doi:10.1016/0092-8674(82)90376-2 · Cited by 662
Self-citationSasmono, R. T., Oceandy, D., Pollard, J. W., Tong, W., Pavli, P., Wainwright, B. J., Ostrowski, M. C., Himes, S. R., & Hume, D. A. (2003) · Blood · doi:10.1182/blood-2002-02-0569 · Cited by 662 · cited 2×
“Maximal CSF-1R expression in differentiated monocytes/macrophages requires a highly conserved 330 bp sequence enhancer element located in the 30 end of intron 2, known as Fms-intronic regulatory element (FIRE), which also has reverse promoter activity (Himes et al. 2001; Sasmono et al. 2003; Laslo et al. 2006; Sauter…”
Background
Research works printed but not linked: 2
- Chitu V, Stanley ER. 2009. PSTPIP1 and PSTPIP2/MAYP. In The Pombe Cdc15 homology proteins (ed. Aspenstrom P), pp. 49-61. Landes Bioscience, Austin, Texas.
- Chitu V, Stanley ER. 2014. CSF-1 receptor. In The receptor tyrosine kinase handbook (ed. Wheeler DL, Yarden Y). Springer, New York (in press).
Cited by
Targeting macrophages: therapeutic approaches in cancer
Cassetta, L., & Pollard, J. W. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.169 · Cited by 2,048
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., Gilfillan, S., Krishnan, G. M., Sudhakar, S., Zinselmeyer, B. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.049 · Cited by 1,736
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
Cannarile, M. A., Weisser, M., Jacob, W., Jegg, A.-M., Ries, C. H., & Rüttinger, D. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0257-y · Cited by 1,020
Macrophage-Based Approaches for Cancer Immunotherapy
Anderson, N. R., Minutolo, N. G., Gill, S., & Klichinsky, M. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2990 · Cited by 698
GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation
Becher, B., Tugues, S., & Greter, M. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.026 · Cited by 593
Gruber, C. N., Patel, R. S., Trachtman, R., Lepow, L., Amanat, F., Krammer, F., Wilson, K. M., Onel, K., Geanon, D., Tuballes, K., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.034 · Cited by 551
Tumor‐associated macrophages in liver cancer: From mechanisms to therapy
Cheng, K., Cai, N., Zhu, J., Yang, X., Liang, H., & Zhang, W. (2022) · Cancer Communications · doi:10.1002/cac2.12345 · Cited by 460
Kaplanov, I., Carmi, Y., Kornetsky, R., Shemesh, A., Shurin, G. V., Shurin, M. R., Dinarello, C. A., Voronov, E., & Apte, R. N. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812266115 · Cited by 445
A lipase-independent pathway of lipid release and immune modulation by adipocytes
Flaherty, S. E., Grijalva, A., Xu, X., Ables, E., Nomani, A., & Ferrante, A. W. (2019) · Science · doi:10.1126/science.aaw2586 · Cited by 382
Tumor Immune Microenvironment during Epithelial–Mesenchymal Transition
Taki, M., Abiko, K., Ukita, M., Murakami, R., Yamanoi, K., Yamaguchi, K., Hamanishi, J., Baba, T., Matsumura, N., & Mandai, M. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4459 · Cited by 351
Emerging Roles for CSF-1 Receptor and its Ligands in the Nervous System
Chitu, V., Gokhan, Ş., Nandi, S., Mehler, M. F., & Stanley, E. R. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.03.005 · Cited by 362
Self-citationMajor pathways involved in macrophage polarization in cancer
Kerneur, C., Cano, C. E., & Olive, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1026954 · Cited by 337
T cell–induced CSF1 promotes melanoma resistance to PD1 blockade
Neubert, N. J., Schmittnaegel, M., Bordry, N., Nassiri, S., Wald, N., Martignier, C., Tillé, L., Homicsko, K., Damsky, W., Maby-El Hajjami, H., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan3311 · Cited by 308
TREM2 regulates microglial cell activation in response to demyelination in vivo
Cantoni, C., Bollman, B., Licastro, D., Xie, M., Mikesell, R., Schmidt, R., Yuede, C. M., Galimberti, D., Olivecrona, G., Klein, R. S., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1388-1 · Cited by 296
Radiation-induced tumor immune microenvironments and potential targets for combination therapy
Guo, S., Yao, Y., Tang, Y., Xin, Z., Wu, D., Ni, C., Huang, J., Wei, Q., & Zhang, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01462-z · Cited by 242
Roles of Mitogen-Activated Protein Kinases in Osteoclast Biology
Lee, K., Seo, I., Choi, M. H., & Jeong, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103004 · Cited by 251
Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape
Osipov, A., Saung, M. T., Zheng, L., & Murphy, A. G. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0667-0 · Cited by 241
The M-CSF receptor in osteoclasts and beyond
Mun, S. H., Park, P. S. U., & Park-Min, K.-H. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0484-z · Cited by 241
Endometriosis-Associated Macrophages: Origin, Phenotype, and Function
Hogg, C., Horne, A. W., & Greaves, E. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00007 · Cited by 238
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity
Hoves, S., Ooi, C.-H., Wolter, C., Sade, H., Bissinger, S., Schmittnaegel, M., Ast, O., Giusti, A. M., Wartha, K., Runza, V., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171440 · Cited by 219
Gomez-Roca, C. A., Italiano, A., Le Tourneau, C., Cassier, P. A., Toulmonde, M., D’Angelo, S. P., Campone, M., Weber, K. L., Loirat, D., Cannarile, M. A., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz163 · Cited by 213
CSF‐1 Controls Cerebellar Microglia and Is Required for Motor Function and Social Interaction
Kana, V., Desland, F. A., Casanova-Acebes, M., Ayata, P., Badimon, A., Nabel, E., Yamamuro, K., Sneeboer, M., Tan, I.-L., Flanigan, M. E., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20182037 · Cited by 220
Self-citationHu, E., Li, Z., Li, T., Yang, X., Ding, R., Jiang, H., Su, H., Cheng, M., Yu, Z., Li, H., et al. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00745-5 · Cited by 192
Boulakirba, S., Pfeifer, A., Mhaidly, R., Obba, S., Goulard, M., Schmitt, T., Chaintreuil, P., Calleja, A., Furstoss, N., Orange, F., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18433-4 · Cited by 201
Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials
Zhang, W., Wang, M., Ji, C., Liu, X., Gu, B., & Dong, T. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116930 · Cited by 178
Function of CSF1 and IL34 in Macrophage Homeostasis, Inflammation, and Cancer
Lin, W., Xu, D., Austin, C. D., Caplazi, P., Senger, K., Sun, Y., Jeet, S., Young, J., Delarosa, D., Suto, E., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02019 · Cited by 190
Ramesh, A., Kumar, S., Nandi, D., & Kulkarni, A. (2019) · Advanced Materials · doi:10.1002/adma.201904364 · Cited by 187
Sedighzadeh, S. S., Khoshbin, A. P., Razi, S., Keshavarz-Fathi, M., & Rezaei, N. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-1241 · Cited by 189
Benner, B., Good, L., Quiroga, D., Schultz, T. E., Kassem, M., Carson, W. E., Cherian, M. A., Sardesai, S., & Wesolowski, R. (2020) · Drug Design, Development and Therapy · doi:10.2147/dddt.s253232 · Cited by 177
CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment
Wen, J., Wang, S., Guo, R., & Liu, D. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114884 · Cited by 181
Pathological angiogenesis and inflammation in tissues
Jeong, J.-H., Ojha, U., & Lee, Y. M. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01287-2 · Cited by 174
Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies
Zhu, S., Yi, M., Wu, Y., Dong, B., & Wu, K. (2021) · Experimental Hematology & Oncology · doi:10.1186/s40164-021-00252-z · Cited by 178
Wiehagen, K. R., Girgis, N. M., Yamada, D. H., Smith, A. A., Chan, S. R., Grewal, I. S., Quigley, M., & Verona, R. I. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0258 · Cited by 162
Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling
Liu, C., Lu, H., Wang, H., Loo, A., Zhang, X., Yang, G., Kowal, C., Delach, S., Wang, Y., Goldoni, S., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2718 · Cited by 167
“AACRJournals.org | 342 signaling in T cells and CSF1R signaling in TAMs.”
BackgroundInfluentialCSF1R signaling is a regulator of pathogenesis in progressive MS
Hagan, N., Kane, J. L., Grover, D., Woodworth, L., Madore, C., Saleh, J., Sancho, J., Liu, J., Li, Y., Proto, J., et al. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-03084-7 · Cited by 165
Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases
Hamilton, J. A., Cook, A. D., & Tak, P. P. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.231 · Cited by 160
Regulation of Embryonic and Postnatal Development by the CSF-1 Receptor
Chitu, V., & Stanley, E. R. (2017) · Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.10.004 · Cited by 161
Self-citationHan, J., Chitu, V., Stanley, E. R., Wszolek, Z. K., Karrenbauer, V. D., & Harris, R. A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04225-1 · Cited by 161
Self-citationMengos, A. E., Gastineau, D. A., & Gustafson, M. P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01147 · Cited by 160
Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
Wang, Q., Shen, X., Chen, G., & Du, J. (2022) · Cancers · doi:10.3390/cancers14122928 · Cited by 160
Sehgal, A., Irvine, K. M., & Hume, D. A. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101509 · Cited by 174
The twin cytokines interleukin-34 and CSF-1: masterful conductors of macrophage homeostasis
Muñoz-García, J., Cochonneau, D., Télétchéa, S., Moranton, E., Lanoé, D., Brion, R., Lézot, F., Heymann, M., & Heymann, D. (2020) · Theranostics · doi:10.7150/thno.50683 · Cited by 167
Caescu, C. I., Guo, X., Tesfa, L., Bhagat, T. D., Verma, A. K., Zheng, D., & Stanley, E. R. (2015) · Blood · doi:10.1182/blood-2014-10-608000 · Cited by 166
Self-citationSignaling pathways in macrophages: molecular mechanisms and therapeutic targets
Li, M., Wang, M., Wen, Y., Zhang, H., Zhao, G., & Gao, Q. (2023) · MedComm · doi:10.1002/mco2.349 · Cited by 184
Kitamura, T., Doughty-Shenton, D., Cassetta, L., Fragkogianni, S., Brownlie, D., Kato, Y., Carragher, N. O., & Pollard, J. W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.02004 · Cited by 161
Interleukin-34, a comprehensive review
Baghdadi, M., Umeyama, Y., Hama, N., Kobayashi, T., Han, N., Wada, H., & Seino, K.-I. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr1117-457r · Cited by 153
Activated microglia drive demyelination via CSF1R signaling
Marzan, D. E., Brügger‐Verdon, V., West, B. L., Liddelow, S., Samanta, J., & Salzer, J. L. (2021) · Glia · doi:10.1002/glia.23980 · Cited by 172
Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders
Stanford, S. M., & Bottini, N. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00618-w · Cited by 151
Hofer, T. P. J., Zawada, A. M., Frankenberger, M., Skokann, K., Satzl, A. A., Gesierich, W., Schuberth, M., Levin, J., Danek, A., Rotter, B., et al. (2015) · Blood · doi:10.1182/blood-2015-06-651331 · Cited by 141
In situ mapping identifies distinct vascular niches for myelopoiesis
Zhang, J., Wu, Q., Johnson, C. B., Pham, G. H., Kinder, J. M., Olsson, A., Slaughter, A., May, M. L., Weinhaus, B., D’Alessandro, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03201-2 · Cited by 131
Defects in Macrophage Reprogramming in Cancer Therapy: The Negative Impact of PD-L1/PD-1
Cai, H., Zhang, Y., Wang, J., & Gu, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.690869 · Cited by 140
Protein kinases: drug targets for immunological disorders
Castelo‐Soccio, L. A., Kim, H., Gadina, M., Schwartzberg, P. L., Laurence, A. D. J., & O’Shea, J. J. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00877-7 · Cited by 135
Phenotypic impacts of CSF1R deficiencies in humans and model organisms
Hume, D. A., Caruso, M., Ferrari-Cestari, M., SUMMERS, K. M., Pridans, C., & Irvine, K. M. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0519-143r · Cited by 143
Tuning the Tumor Myeloid Microenvironment to Fight Cancer
Jahchan, N. S., Mujal, A. M., Pollack, J. L., Binnewies, M., Sriram, V., Reyno, L. M., & Krummel, M. F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01611 · Cited by 129
Cao, X., Chen, J., Li, B., Dang, J., Zhang, W., Zhong, X., Wang, C., Raoof, M., Sun, Z., Yu, J., et al. (2022) · Science Advances · doi:10.1126/sciadv.abl9171 · Cited by 126
Baghdadi, M., Endo, H., Takano, A., Ishikawa, K., Kameda, Y., Wada, H., Miyagi, Y., Yokose, T., Ito, H., Nakayama, H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18796-8 · Cited by 119
Role of the colony-stimulating factor (CSF)/CSF-1 receptor axis in cancer
Achkova, D., & Maher, J. F. (2016) · Biochemical Society Transactions · doi:10.1042/bst20150245 · Cited by 118
Barnestein, R., Galland, L., Kalfeist, L., Ghiringhelli, F., Ladoire, S., & Limagne, E. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2120676 · Cited by 123
Stadler, M., Pudelko, K., Biermeier, A., Walterskirchen, N., Gaigneaux, A., Weindorfer, C., Harrer, N. E., Klett, H., Hengstschläger, M., Schüler, J. B., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.07.006 · Cited by 121
Macrophage-Derived Cholesterol Contributes to Therapeutic Resistance in Prostate Cancer
El-Kenawi, A., Dominguez‐Viqueira, W., Liu, M., Awasthi, S., Abraham-Miranda, J., Keske, A., Steiner, K. K., Noel, L. C., Serna, A. N., Dhillon, J., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-4028 · Cited by 121
Grabert, K., Sehgal, A., Irvine, K. M., Wollscheid-Lengeling, E., Ozdemir, D. D., Stables, J., Luke, G. A., Ryan, M. D., Adamson, A., Humphreys, N. E., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000835 · Cited by 114
The expanding world of tissue‐resident macrophages
Jenkins, S. J., & Allen, J. E. (2021) · European Journal of Immunology · doi:10.1002/eji.202048881 · Cited by 128
Targeting CSF-1R represents an effective strategy in modulating inflammatory diseases
Xiang, C., Li, H., & Tang, W. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106566 · Cited by 118
Insights Into the Role of CSF1R in the Central Nervous System and Neurological Disorders
Hu, B., Duan, S., Wang, Z., Li, X., Zhou, Y., Zhang, X., Zhang, Y., Xu, H., & Zheng, H. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.789834 · Cited by 127
Single-cell RNA-Seq reveals changes in immune landscape in post-traumatic osteoarthritis
Sebastian, A., Hum, N. R., McCool, J. L., Wilson, S. P., Murugesh, D. K., Martin, K. A., Rios‐Arce, N. D., Amiri, B., Christiansen, B., & Loots, G. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.938075 · Cited by 122
Quantifying microglial morphology: an insight into function
Green, T. R. F., & Rowe, R. K. (2024) · Clinical & Experimental Immunology · doi:10.1093/cei/uxae023 · Cited by 125
Pagán, A. J., Yang, C.-T., Cameron, J. R., Swaim, L. E., Ellett, F. E., Lieschke, G. J., & Ramakrishnan, L. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.06.008 · Cited by 117
Poh, A. R., & Ernst, M. (2021) · Cancers · doi:10.3390/cancers13122860 · Cited by 106
Imatinib prevents lung cancer metastasis by inhibiting M2-like polarization of macrophages
Yao, Z., Zhang, J., Zhang, B., Liang, G., Chen, X., Yao, F., Xu, X., Wu, H., He, Q., Ding, L., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.05.002 · Cited by 108
Morales, R. A., & Allende, M. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00253 · Cited by 114
Emerging roles of IL-34 in health and disease
Lelios, I., Cansever, D., Utz, S. G., Mildenberger, W., Stifter, S. A., & Greter, M. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190290 · Cited by 109
Cytokine mediators of chronic graft-versus-host disease
MacDonald, K. P. A., Blazar, B. R., & Hill, G. R. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90593 · Cited by 104
Mamedov, M. R., Scholzen, A., Nair, R. V., Cumnock, K., Kenkel, J. A., Oliveira, J. H. M., Trujillo, D. L., Saligrama, N., Zhang, Y., Rubelt, F., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.01.009 · Cited by 114
Ngai, D., Schilperoort, M., & Tabas, I. A. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00921-9 · Cited by 112
The generation, activation, and polarization of monocyte-derived macrophages in human malignancies
Chaintreuil, P., Kerreneur, E., Bourgoin, M., Savy, C., Favreau, C., Robert, G., Jacquel, A., & Auberger, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1178337 · Cited by 113
Soncin, I., Sheng, J., Chen, Q., Foo, S., Duan, K., Lum, J., Poidinger, M., Zolezzi, F., Karjalainen, K., & Ruedl, C. (2018) · Nature Communications · doi:10.1038/s41467-018-02834-8 · Cited by 102
The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review
Mazzarella, L., Duso, B. A., Trapani, D., Belli, C., D’Amico, P., Ferraro, E., Viale, G., & Curigliano, G. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2019.04.035 · Cited by 105
Microglia replacement halts the progression of microgliopathy in mice and humans
Wu, J., Wang, Y., Li, X., Ouyang, P., Cai, Y., He, Y., Zhang, M., Luan, X., Jin, Y., Wang, J., et al. (2025) · Science · doi:10.1126/science.adr1015 · Cited by 113
Papah, M. B., Brannick, E. M., Schmidt, C. J., & Abasht, B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207346 · Cited by 116
Post-Ischaemic Immunological Response in the Brain: Targeting Microglia in Ischaemic Stroke Therapy
Rawlinson, C., Jenkins, S. I., Thei, L., Dallas, M. L., & Chen, R. (2020) · Brain Sciences · doi:10.3390/brainsci10030159 · Cited by 103
Macrophages: Subtypes, Distribution, Polarization, Immunomodulatory Functions, and Therapeutics
Peng, M., Li, N., Wang, H., Li, Y., Liu, H., Luo, Y., Lang, B., Zhang, W., Li, S., Tian, L., et al. (2025) · MedComm · doi:10.1002/mco2.70304 · Cited by 121
Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases
Chen, M., & Hung, M. (2015) · FEBS Journal · doi:10.1111/febs.13342 · Cited by 108
The origins and formation of bone-resorbing osteoclasts
Elson, A., Anuj, A., Barnea-Zohar, M., & Reuven, N. (2022) · Bone · doi:10.1016/j.bone.2022.116538 · Cited by 95
Bipolar Tumor-Associated Macrophages in Ovarian Cancer as Targets for Therapy
Gupta, V. G., Yull, F. E., & Khabele, D. (2018) · Cancers · doi:10.3390/cancers10100366 · Cited by 96
New Strategies in Bladder Cancer: A Second Coming for Immunotherapy
Ghasemzadeh, A., Bivalacqua, T. J., Hahn, N. M., & Drake, C. G. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1135 · Cited by 102
Chen, L., Oke, T. F., Siegel, N. M., Cojocaru, G., Tam, A. J., Blosser, R. L., Swailes, J., Ligon, J. A., Lebid, A., Morris, C. D., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3416 · Cited by 92
Recent Advances of Colony-Stimulating Factor-1 Receptor (CSF-1R) Kinase and Its Inhibitors
El–Gamal, M. I., Al-Ameen, S. K., Al-Koumi, D. M., Hamad, M. G., Jalal, N. A., & Oh, C. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00873 · Cited by 95
Macrophage depletion ameliorates nephritis induced by pathogenic antibodies
Chalmers, S. A., Chiţu, V., Herlitz, L., Sahu, R. K., Stanley, E. R., & Putterman, C. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.11.007 · Cited by 89
Self-citationMyeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade
Peranzoni, E., Ingangi, V., Masetto, E., Pinton, L., & Marigo, I. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01590 · Cited by 89
Polyphenols as Immunomodulatory Compounds in the Tumor Microenvironment: Friends or Foes?
Focaccetti, C., Izzi, V., Benvenuto, M., Fazi, S., Ciuffa, S., Giganti, M. G., Potenza, V., Manzari, V., Modesti, A., & Bei, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071714 · Cited by 88
Microglia as Therapeutic Target for Radiation-Induced Brain Injury
Liu, Q., Yan, H., Duan, M., Yang, Q., Ren, B., & Tang, F. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158286 · Cited by 88
Enhancing radiotherapy-induced anti-tumor immunity via nanoparticle-mediated STING agonist synergy
Zeng, Q., Liu, M., Wang, Z., Zhou, R., & Ai, K. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02366-y · Cited by 93
Bone Remodeling and the Role of TRAF3 in Osteoclastic Bone Resorption
Boyce, B. F., Li, J., Xing, L., & Yao, Z. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02263 · Cited by 86
Chadarevian, J. P., Hasselmann, J., Lahian, A., Capocchi, J. K., Escobar, A., Lim, T. E., Le, L., Tu, C., Nguyen, J., Kiani Shabestari, S., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.05.023 · Cited by 83
CSF1R Stimulation Promotes Increased Neuroprotection by CD11c+ Microglia in EAE
Wlodarczyk, A., Benmamar-Badel, A., Cédile, O., Jensen, K. N., Kramer, I., Elsborg, N. B., & Owens, T. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00523 · Cited by 81
“Development, maintenance and proliferation of microglia depend on activation of Colony Stimulating Factor-1 receptor (CSF1R), a key signaling pathway in myeloid cell development (Stanley and Chitu, 2014).”
BackgroundTumor-associated macrophage-related strategies for glioma immunotherapy
Tang, F., Wang, Y., Zeng, Y., Xiao, A., Tong, A., & Xu, J. (2023) · npj Precision Oncology · doi:10.1038/s41698-023-00431-7 · Cited by 87
Lynch, D. S., Jaunmuktane, Z., Sheerin, U., Phadke, R., Brandner, S., Milonas, I., Dean, A. F., Bajaj, N. P. S., McNicholas, N., Costello, D. J., et al. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-310788 · Cited by 80
Trías, E., Kovacs, M., King, P. H., Si, Y., Kwon, Y., Varela, V., Ibarburu, S., Moura, I. C., Hermine, O., Beckman, J. S., et al. (2019) · Glia · doi:10.1002/glia.23768 · Cited by 84
Inhaled seralutinib exhibits potent efficacy in models of pulmonary arterial hypertension
Galkin, A., Sitapara, R. A., Clemons, B., Garcia, E., Kennedy, M., Guimond, D. M., Carter, L., Douthitt, A. J., Osterhout, R. E., Gandjeva, A., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.02356-2021 · Cited by 78
Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma
Truxová, I., Cibula, D., Špíšek, R., & Fucikova, J. P. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005968 · Cited by 81
Metadata
- Authors
- Stanley, E. R., & Chitu, V.
- Affiliations
- Albert Einstein College of Medicine (US)
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2014-06-01
- Volume
- 6
- Issue
- 6
- Pages
- a021857-a021857
- ISSN
- 1943-0264 (ISSN-L)
- PMC
- PMC4031967
- OpenAlex
- W2115736737
- Cited by
- 825
- References
- 211
- Citations by year
- 2026: 65 · 2025: 101 · 2024: 114 · 2023: 104 · 2022: 95 · 2021: 91 · 2020: 67 · 2019: 63 · 2018: 49 · 2017: 26 · 2016: 25 · 2015: 19 · 2014: 6
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (32551, PO1#CA100324, CA13330, CA100324)
- National Cancer Institute (CA-32551, R01CA032551, 5 P30-CA13330, P01CA100324, P30CA013330)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (K01AR054486)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- CSF-1 receptor, colony-stimulating factor 1, IL-34, myeloid cells, macrophage development, osteoclasts, Langerhans cells, Paneth cells, microglia, receptor structure, ligand binding, macrophage differentiation, macrophage chemotaxis, innate immunity, neuroinflammation
- MeSH terms
- Animals, Humans, Ligands, Protein Conformation, Signal Transduction, Receptor, Macrophage Colony-Stimulating Factor, Evolution, Molecular, Myeloid Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.